Tamoxifen enhancement of TNF-α induced MnSOD expression: modulation of NF-κB dimerization
Authors:
- Kelley KininghamKKKelley Kiningham
- Edward J KasarskisEKEdward J Kasarskis
- Wanida IttaratWIWanida Ittarat
- Daret K St.ClairDSDaret K St.Clair
- 16 May 2002
- journal article
- Published by Springer Nature in Oncogene
- Vol. 21 (22) , 3603-3610
Abstract
Manganese superoxide dismutase (MnSOD) has been shown to suppress the development of cancer. Tamoxifen (TAM), a nonsteroidal anti-estrogen that is widely used in chemotherapy, is known to be a modulator of antioxidant status. However, the mechanism by which TAM mediates antioxidant enzyme induction remains unclear. In this study we investigated TAM enhancement of MnSOD induction by TNF-alpha. The results show that co-treatment with TAM and TNF-alpha increases the MnSOD promoter/enhancer driven luciferase activity, MnSOD mRNA and protein levels. Interestingly, co-treatment with TAM and TNF-alpha drastically decreases the binding activity of the p50/p50 homodimer and increases that of the p50/p65 heterodimer compared to TNF-alpha alone. This change in DNA binding could not be attributed to a decrease in the level of p50, its precursor, p105, or its inhibitors. Furthermore, TAM did not enhance degradation of IkappaB-alpha. These results suggest that p50/p50 homodimer may act as an inhibitory complex of MnSOD expression. Modulation of the DNA binding activity in favor of the p50/p65 complex may enhance NF-kappaB mediated induction of MnSOD by TAM. These findings reveal a potential novel mechanism for the induction of the human MnSOD gene.Keywords
This publication has 34 references indexed in Scilit:
- Hydrogen peroxide-induced apoptosis is CD95-independent, requires the release of mitochondria-derived reactive oxygen species and the activation of NF-κBOncogene, 1999
- NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune ResponsesAnnual Review of Immunology, 1998
- Nuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory DiseasesNew England Journal of Medicine, 1997
- Function and Activation of NF-kappaB in the Immune SystemAnnual Review of Immunology, 1994
- High levels of c-rel expression are associated with programmed cell death in the developing avian embryo and in bone marrow cells in vitroCell, 1993
- Generation of p50 subunit of NF-kB by processing of p105 through an ATP-dependent pathwayNature, 1991
- The inducible transcription activator NF-κB: regulation by distinct protein subunitsBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1991
- IκB: a Specific Inhibitor of the NF-κB Transcription FactorScience, 1988
- Prooxidant States and Tumor PromotionScience, 1985
- Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nucleiNucleic Acids Research, 1983